• Is there a need for a new cardiometabolic medicine subspecialty?

    11 days ago - By Healio

    We know that obesity prevalence continues to increase, that metabolic syndrome follows and a higher incidence of type 2 diabetes is now before us.
    The interactions between these metabolic diseases and CVD is increasingly important. Imagine you have a patient admitted to the hospital with acute MI, who may have had impaired glucose tolerance, and now has type 2 diabetes. Who sees this patient at discharge? The hospitalist cardiologist will certainly not see this individual. Instead, he or she will enter into a new space with a new cardiologist. Considering the new trials with GLP-1 receptor
    Read more ...